Updated: Provention prices drug to delay type I diabetes at $193K as FDA nod kicks off US launch with Sanofi

For the first time, the FDA has approved a drug to delay the onset of type I diabetes, potentially giving children, teenagers and young adults …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Up­dat­ed: Proven­tion prices drug to de­lay type I di­a­betes at $193K as FDA nod kicks off US launch with Sanofi